It should be noted that in our survey of five prostate (PC3, CWR22Rv1, DU145) and breast cancer (MDA-MB-231 and BT-459) ADI-resistant cell lines, all restored ASS1 expression. This evidence concerns the gene ASS1 and breast carcinoma.